Pennsylvania Business Report

Eli Lilly choses Pennsylvania for medicine, device manufacturing facility

Featured
By Liz Carey  |  February 2, 2026

Eli Lilly and Company announced Friday that it has selected the Lehigh Valley of Pennsylvania as the site of its new injectable medicine and device manufacturing facility. The company said it will invest $3.5 billion to develop weight-loss therapies including retatrutide, a first-in-class investigational GIP, GLP-1 and glucagon triple hormone receptor agonist. The facility, located in Fogelsville, PA, will be the company’s fourth announced site since February 2025, and is part of its commi...

Read More

As PA budget looms, energy coalition urges Shapiro to hold the line on new taxes

Featured
By Kim Riley  |  January 30, 2026

Allentown company wins $140M in NASA contracts

Featured
By Liz Carey  |  January 30, 2026

Cloud-based logistics, fulfillment services provider opens Northampton facility

Featured
By Melina Druga  |  January 29, 2026
More News »